Share-based Payment Arrangement, Expense in USD of Oncotelic Therapeutics, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q1 2025.
  • Oncotelic Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $0.000.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $0.000.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $0.000, a 100% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $900K, unchanged from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Oncotelic Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $0 $0 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 $600K $0 -$300K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $900K $275K Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 $300K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-18
Q2 2022 $25K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-22
Q1 2022 $300K +$300K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q3 2021 $300K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-18
Q1 2021 $0 -$2.1M -100% Jan 1, 2021 Mar 31, 2021 10-Q 2021-11-22
Q1 2020 $2.1M +$1.76M +516% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q1 2020 $2.1M +$1.76M +516% Feb 1, 2020 Feb 29, 2020 10-Q 2021-11-22
Q1 2019 $341K +$157K +85.3% Apr 1, 2019 Apr 30, 2019 10-K 2021-04-15
Q1 2019 $212K +$28K +15.2% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-15
Q1 2018 $184K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q3 2013 $200K Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-13

Oncotelic Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 $0 Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $0 -$900K -100% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $900K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 $900K +$900K Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-20
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2018 $744K -$91K -10.9% Jan 1, 2018 Dec 31, 2018 10-K 2019-04-10
2017 $835K +$31K +3.86% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-10
2016 $804K -$2K -0.25% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-17
2015 $806K +$392K +94.7% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 $414K -$265K -39% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
2013 $679K +$168K +32.9% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 $511K -$340K -40% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-30
2011 $851K +$1.54M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-20
2010 -$687K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.